Stempeutics’ allogeneic cell therapy gets DCGI approval, Cipla to market and distribute… EP News Bureau Aug 20, 2020 Indicated for the treatment of CLI due to Buerger’s Disease and Atherosclerotic Peripheral Arterial Disease, it is the first…
